A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global market for Point-of-Care Infectious Disease Diagnostics & Testing was estimated to be worth US$ 2053.6 million in 2023 and is forecast to a readjusted size of US$ 2764.3 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Point-of-Care Infectious Disease Diagnostics & Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”. Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Point-of-Care Infectious Disease Diagnostics & Testing market, including market size, share, demand, industry development status, and forecasts for the next few years.
The report provides advanced statistics and information on global market conditions and studies the strategic patterns adopted by renowned players across the globe. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.
This information will help stakeholders make informed decisions and develop effective strategies for growth. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth. This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/2336793/point-of-care-infectious-disease-diagnostics---testing
Global Point-of-Care Infectious Disease Diagnostics & Testing Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends, providing a detailed analysis of the production volume for each type from 2019 to 2030, as well as the production volume by region during the same period.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The Point-of-Care Infectious Disease Diagnostics & Testing market is segmented as below:
By Company
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Segment by Type
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Segment by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Each chapter of the report provides detailed information for readers to further understand the Point-of-Care Infectious Disease Diagnostics & Testing market:
Chapter 1: Point-of-Care Infectious Disease Diagnostics & Testing Market Product Definition, Product Types, Sales Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2019 to 2024.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Household Hazardous Waste Disposal, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Point-of-Care Infectious Disease Diagnostics & Testing industry.
Chapter 3: Point-of-Care Infectious Disease Diagnostics & Testing Market Historical (2019-2023) and forecast (2024-2030) sales and revenue analysis of Point-of-Care Infectious Disease Diagnostics & Testing in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Point-of-Care Infectious Disease Diagnostics & Testing Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2019 to 2024.
Chapter 5 to 9: Point-of-Care Infectious Disease Diagnostics & Testing Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Point-of-Care Infectious Disease Diagnostics & Testing introduction, etc. Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, including raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Point-of-Care Infectious Disease Diagnostics & Testing market based on comprehensive survey.
Chapter 14: Methodology and Data Sources.
Table of Contents
1 Point-of-Care Infectious Disease Diagnostics & Testing Market Overview
1.1Point-of-Care Infectious Disease Diagnostics & Testing Product Overview
1.2 Point-of-Care Infectious Disease Diagnostics & Testing Market by Type
1.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
1.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Overview by Type (2019-2030)
1.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size Review by Type (2019-2024)
1.3.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2025-2030)
1.4 Key Regions Market Size by Type
1.4.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Breakdown by Type (2019-2024)
1.4.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Breakdown by Type (2019-2024)
1.4.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Breakdown by Type (2019-2024)
1.4.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Sales Breakdown by Type (2019-2024)
1.4.5 Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Breakdown by Type (2019-2024)
2 Point-of-Care Infectious Disease Diagnostics & Testing Market Competition by Company
2.1 Global Top Players by Point-of-Care Infectious Disease Diagnostics & Testing Sales (2019-2024)
2.2 Global Top Players by Point-of-Care Infectious Disease Diagnostics & Testing Revenue (2019-2024)
2.3 Global Top Players by Point-of-Care Infectious Disease Diagnostics & Testing Price (2019-2024)
2.4 Global Top Manufacturers Point-of-Care Infectious Disease Diagnostics & Testing Manufacturing Base Distribution, Sales Area, Product Type
2.5 Point-of-Care Infectious Disease Diagnostics & Testing Market Competitive Situation and Trends
2.5.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Rate (2019-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Point-of-Care Infectious Disease Diagnostics & Testing Sales and Revenue in 2023
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2023)
2.7 Date of Key Manufacturers Enter into Point-of-Care Infectious Disease Diagnostics & Testing Market
2.8 Key Manufacturers Point-of-Care Infectious Disease Diagnostics & Testing Product Offered
2.9 Mergers & Acquisitions, Expansion
...
Overall, this report strives to provide you with the insights and information you need to make informed business decisions and stay ahead of the competition.
To contact us and get this report: https://www.qyresearch.com/contact-us
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
EN: https://www.qyresearch.com
JP: https://www.qyresearch.co.jp